Ran Taube
Impact in
- Virology top 1%
- HIV Research and Treatment
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment
- SARS-CoV-2 and COVID-19 Research
Papers in
- Virology 26
- HIV Research and Treatment 26
-
- HIV/AIDS drug development and treatment 12
- SARS-CoV-2 and COVID-19 Research 6
- Co-authors
- Koh FujinagaB. Matija PeterlinDan IrwinDavid H. PriceAlona KuzminaSheng‐Hao ChaoEdward A. SausvilleAdrian M. Senderowicz
- Journals
- Journal of Biological Chemistry (4 papers)Virology (4 papers)PLoS ONE (4 papers)ACS Chemical Neuroscience (3 papers)European Journal of Biochemistry (3 papers)
- Partner nations
- IsraelUnited StatesGermany
In The Last Decade
Ran Taube
51 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 106
- Virology 767
- Infectious Diseases 532
- Molecular Biology 1.2k
- Immunology 344
- Oncology 277
Countries citing papers authored by Ran Taube
This map shows the geographic impact of Ran Taube's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ran Taube with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ran Taube more than expected).
Fields of papers citing papers by Ran Taube
This network shows the impact of papers produced by Ran Taube. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ran Taube. The network helps show where Ran Taube may publish in the future.
Co-authors
The 25 scholars most cited alongside Ran Taube, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 6 | |
| 6 | 2023 | 4 | |
| 7 | 2022 | 8 | |
| 8 | 2021 | 20 | |
| 9 | 2021 | 118 | |
| 10 | 2020 | 44 | |
| 11 | 2019 | 16 | |
| 12 | 2018 | 9 | |
| 13 | 2017 | 12 | |
| 14 | 2012 | 2 | |
| 15 | 2012 | 43 | |
| 16 | 2012 | 38 | |
| 17 | 2008 | 8 | |
| 18 | 2002 | 53 | |
| 19 | 1999 | 71 | |
| 20 | 1997 | 38 |
About Ran Taube
Ran Taube is a scholar working on Virology, Infectious Diseases, Immunology, Endocrinology and Molecular Biology, having authored 52 papers that have together received 2.0k indexed citations. Recurring topics across this work include HIV Research and Treatment (26 papers), RNA Research and Splicing (13 papers), HIV/AIDS drug development and treatment (12 papers), Immune Cell Function and Interaction (8 papers), Alzheimer's disease research and treatments (7 papers), Virus-based gene therapy research (7 papers), SARS-CoV-2 and COVID-19 Research (6 papers) and Cholinesterase and Neurodegenerative Diseases (4 papers). The work is most often cited by research in Virology (767 citations), Infectious Diseases (532 citations), Molecular Biology (1.2k citations), Immunology (344 citations) and Oncology (277 citations). Ran Taube has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Koh Fujinaga, B. Matija Peterlin, Dan Irwin, David H. Price, Alona Kuzmina, Sheng‐Hao Chao, Edward A. Sausville, Adrian M. Senderowicz, Ye-Hong Huang and Xin Lin. Their work appears in journals such as Journal of Biological Chemistry, Virology, PLoS ONE, ACS Chemical Neuroscience and European Journal of Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.